Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.

CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.

Watch a memorial tribute to Dr. Giulio John D'Angio, pioneer in the treatment of children's cancers.

CHOP researchers analyze how some cancer cells resist a groundbreaking cellular therapy, and have found clues to overcoming that resistance.

Researchers at CHOP are working to discover the fundamental mechanisms that subvert normal neural development and orchestrate neuroblastoma tumorigenesis, and then to translate this knowledge into more effective and less toxic therapies.

The grand opening of CHOP’s new Clinical Manufacturing Facility highlights its role in manufacturing tools for 21st century precision medicine, to bring innovative treatments to patients.

Two CHOP researchers were on a team that proposes potential ways to avoid future infertility in boys who are treated with chemotherapy and radiation for childhood cancer.

Blocking disease-causing biological signals may lead to a new treatment for the life-threatening childhood blood disorder Fanconi anemia.

CHOP’s pediatric malnutrition screening tool could be implemented to screen all pediatric patients.

The $220,000 award will be directed to a Phase I clinical trial that will investigate the effectiveness of CAR T-cell therapy to treat AML.